Clari Vest Asset Management LLC Aldeyra Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.11 - $11.89 $167,710 - $280,461	23,588 Added 22.16%	130,044 $1.09 Million
Q1 2023 May 08, 2023	BUY	$5.77 - $9.93 $323 - $556	56 Added 0.05%	106,456 $1.06 Million
Q4 2022 Feb 14, 2023	SELL	$5.08 - $7.09 $8,128 - $11,344	-1,600 Reduced 1.48%	106,400 $740,000
Q1 2022 May 04, 2022	SELL	$3.25 - $5.17 $49,400 - $78,584	-15,200 Reduced 12.34%	108,000 $480,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $196,350 - $540,243	56,100 Added 83.61%	123,200 $493,000
Q3 2021 Nov 08, 2021	SELL	$7.94 - $11.31 $4,764 - $6,786	-600 Reduced 0.89%	67,100 $590,000
Q2 2021 Aug 09, 2021	BUY	$10.44 - $14.85 $706,788 - $1.01 Million	67,700 New	67,700 $767,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $278M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.